| Item Type | Name |
|
Academic Article
|
Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy.
|
|
Academic Article
|
Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer.
|
|
Academic Article
|
Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.
|
|
Academic Article
|
High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy.
|
|
Concept
|
Small Cell Lung Carcinoma
|
|
Academic Article
|
Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers.
|
|
Academic Article
|
Non-small cell lung cancer clinical practice guidelines in oncology.
|
|
Academic Article
|
Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
|
|
Academic Article
|
Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone.
|
|
Academic Article
|
Stereotactic body radiation therapy for stage I non-small cell lung cancer.
|
|
Academic Article
|
Patterns of cardiac perfusion abnormalities after chemoradiotherapy in patients with lung cancer.
|
|
Academic Article
|
ACR Appropriateness Criteria? radiation therapy for small-cell lung cancer.
|
|
Academic Article
|
ACR appropriateness criteria nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent.
|
|
Academic Article
|
Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer.
|
|
Academic Article
|
Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomography.
|
|
Academic Article
|
Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer.
|
|
Academic Article
|
Improving radiation conformality in the treatment of non-small cell lung cancer.
|
|
Academic Article
|
Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer.
|
|
Academic Article
|
Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer.
|
|
Academic Article
|
FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy.
|
|
Academic Article
|
Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly.
|
|
Academic Article
|
Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer.
|
|
Academic Article
|
Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer.
|
|
Academic Article
|
Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities.
|
|
Academic Article
|
Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection.
|
|
Academic Article
|
A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
|
|
Academic Article
|
Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
|
|
Academic Article
|
Intrathoracic patterns of failure for non-small-cell lung cancer with positron-emission tomography/computed tomography-defined target delineation.
|
|
Academic Article
|
Cine computed tomography without respiratory surrogate in planning stereotactic radiotherapy for non-small-cell lung cancer.
|
|
Academic Article
|
Consequences of anatomic changes and respiratory motion on radiation dose distributions in conformal radiotherapy for locally advanced non-small-cell lung cancer.
|
|
Academic Article
|
ACR Appropriateness Criteria: nonsurgical treatment for non-small-cell lung cancer: good performance status/definitive intent.
|
|
Academic Article
|
Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer.
|
|
Academic Article
|
ACR Appropriateness Criteria? on Induction and Adjuvant Therapy for Stage N2 Non-Small-Cell Lung Cancer: expert panel on radiation oncology-lung.
|
|
Academic Article
|
Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer.
|
|
Academic Article
|
ACR Appropriateness Criteria? postoperative adjuvant therapy in non-small cell lung cancer.
|
|
Academic Article
|
Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer.
|
|
Academic Article
|
The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy.
|
|
Academic Article
|
Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer.
|
|
Academic Article
|
Coxsackie-adenovirus receptor as a novel marker of stem cells in treatment-resistant non-small cell lung cancer.
|
|
Academic Article
|
Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.
|
|
Academic Article
|
Oncology scan--promising strategies for the treatment of locally-advanced non-small cell lung cancer.
|
|
Academic Article
|
Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone".
|
|
Academic Article
|
Intensity modulated radiation therapy and proton radiotherapy for non-small cell lung cancer.
|
|
Academic Article
|
Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer.
|
|
Academic Article
|
Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer.
|
|
Academic Article
|
Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer.
|
|
Academic Article
|
Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer.
|
|
Academic Article
|
Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms.
|
|
Academic Article
|
Image-guided radiation therapy for non-small cell lung cancer.
|
|
Academic Article
|
Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer.
|
|
Academic Article
|
Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study.
|
|
Academic Article
|
ACR Appropriateness Criteria? nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intent.
|
|
Academic Article
|
Phase I study of celecoxib with concurrent irinotecan, Cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancer.
|
|
Academic Article
|
Individualized hypo/hyperfractionated radiotherapy for non-small cell lung cancer.
|
|
Academic Article
|
Accelerated dose escalation with proton beam therapy for non-small cell lung cancer.
|
|
Academic Article
|
Radiation pneumonitis in patients with non--small-cell lung cancer treated with erlotinib concurrent with thoracic radiotherapy.
|
|
Academic Article
|
Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial.
|
|
Academic Article
|
Progress of clinical research on targeted therapy combined with thoracic radiotherapy for non-small-cell lung cancer.
|
|
Academic Article
|
Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indications.
|
|
Academic Article
|
Proton-based stereotactic ablative radiotherapy in early-stage non-small-cell lung cancer.
|
|
Academic Article
|
ACR appropriateness Criteria? early-stage non-small-cell lung cancer.
|
|
Academic Article
|
Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes.
|
|
Academic Article
|
Use of simultaneous radiation boost achieves high control rates in patients with non-small-cell lung cancer who are not candidates for surgery or conventional chemoradiation.
|
|
Academic Article
|
Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned.
|
|
Academic Article
|
Incidence and predictors of severe acute esophagitis and subsequent esophageal stricture in patients treated with accelerated hyperfractionated chemoradiation for limited-stage small cell lung cancer.
|
|
Academic Article
|
ACR Appropriateness Criteria(?) induction and adjuvant therapy for N2 non-small-cell lung cancer.
|
|
Academic Article
|
Knocking Down Nucleolin Expression Enhances the Radiosensitivity of Non-Small Cell Lung Cancer by Influencing DNA-PKcs Activity.
|
|
Academic Article
|
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.
|
|
Academic Article
|
Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer.
|
|
Academic Article
|
Surgery versus SABR for resectable non-small-cell lung cancer - Authors' reply.
|
|
Academic Article
|
A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927).
|
|
Academic Article
|
Association between Genetic Variants in DNA Double-Strand Break Repair Pathways and Risk of Radiation Therapy-Induced Pneumonitis and Esophagitis in Non-Small Cell Lung Cancer.
|
|
Academic Article
|
MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation
|
|
Academic Article
|
Individualized hypo/hyperfractionated radiotherapy for non-small cell lung cancer
|
|
Academic Article
|
Proton therapy for non-small cell lung cancer
|
|
Academic Article
|
Is surgery still the optimal treatment for stage I non-small cell lung cancer?
|
|
Academic Article
|
Association between genetic variants in DNA double-strand break repair pathways and risk of radiation therapy-induced pneumonitis and esophagitis in non-small cell lung cancer
|
|
Academic Article
|
Prognostic significance of nuclear or cytoplasmic nucleolin expression in human non-small cell lung cancer and its relationship with DNA-PKcs
|
|
Academic Article
|
A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage i peripheral non-small cell lung cancer
|
|
Academic Article
|
Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer
|
|
Academic Article
|
ACR appropriateness criteria® nonsurgical treatment for locally advanced non-small-cell lung cancer
|
|
Academic Article
|
Phase I study of celecoxib with concurrent irinotecan, cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancer
|
|
Academic Article
|
MiRNA-related genetic variations associated with radiotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer
|
|
Academic Article
|
Accelerated dose escalation with proton beam therapy for non-small cell lung cancer
|
|
Academic Article
|
Individualized Radiotherapy by Dose Escalation and Altered Fractionation in Non-Small Cell Lung Cancer
|
|
Academic Article
|
Prospective Study of Patient-Reported Symptom Burden in Patients With Non-Small-Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy
|
|
Academic Article
|
Prognostic significance of nuclear or cytoplasmic nucleolin expression in human non-small cell lung cancer and its relationship with DNA-PKcs.
|
|
Academic Article
|
Prospective Study of Patient-Reported Symptom Burden in Patients With Non-Small-Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy.
|
|
Academic Article
|
Erratum. A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG Oncology RTOG 0915 (NCCTG N0927).
|
|
Academic Article
|
Stereotactic radiotherapy or surgery for early-stage non-small-cell lung cancer - Authors' reply.
|
|
Academic Article
|
Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Optimal sequencing of postoperative radiotherapy and chemotherapy in IIIA-N2 non-small cell lung cancer.
|
|
Academic Article
|
Is surgery still the optimal treatment for stage I non-small cell lung cancer?
|
|
Academic Article
|
Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer.
|
|
Academic Article
|
Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
|
|
Academic Article
|
Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Long-Term Outcomes of Salvage Stereotactic Ablative?Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial.
|
|
Academic Article
|
7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.
|
|
Academic Article
|
Proton therapy for non-small cell lung cancer: Current evidence and future directions.
|
|
Academic Article
|
Patterns and correlates of treatment failure in relation to isodose distribution in non-small cell lung cancer: An analysis of 1522 patients in the modern era.
|
|
Academic Article
|
Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer.
|
|
Academic Article
|
Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer.
|
|
Academic Article
|
Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Controversies in dose-escalation for locally advanced non-small cell lung cancer and the role of proton beam therapy.
|
|
Academic Article
|
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018.
|
|
Academic Article
|
Proton therapy for early-stage non-small cell lung cancer (NSCLC).
|
|
Academic Article
|
Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Dose-escalation of locally advanced non-small cell lung cancer with proton beam therapy.
|
|
Academic Article
|
Impact of Corticosteroid Administration on Outcomes Following Stereotactic Ablative Radiotherapy for Non-small-cell Lung Cancer.
|
|
Academic Article
|
Treatment modes for EGFR mutations in patients with brain metastases from non-small cell lung cancer: controversy, causes, and solutions.
|
|
Academic Article
|
Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms.
|
|
Academic Article
|
Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer.
|
|
Academic Article
|
Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-Small Cell Lung Cancer: A Phase 2 Randomized Trial.
|
|
Academic Article
|
Proton therapy for non-small cell lung cancer: the road ahead.
|
|
Academic Article
|
Trends and Outcomes of Proton Radiation Therapy Use for Non-Small Cell Lung Cancer.
|
|
Academic Article
|
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020.
|
|
Academic Article
|
Metabolic Responses to Metformin in Inoperable Early-stage Non-Small Cell Lung Cancer Treated With Stereotactic Radiotherapy: Results of a Randomized Phase II Clinical Trial.
|
|
Academic Article
|
An improved method for analyzing and reporting patterns of in-field recurrence after stereotactic ablative radiotherapy in early-stage non-small cell lung cancer.
|
|
Academic Article
|
Tyrosine Kinase Inhibitor Resistance Increased the Risk of Cerebral Radiation Necrosis After Stereotactic Radiosurgery in Brain Metastases of Non-small-Cell Lung Cancer: A Multi-Institutional Retrospective Case-Control Study.
|
|
Academic Article
|
Lyman-Kutcher-Burman normal tissue complication probability modeling for radiation-induced esophagitis in non-small cell lung cancer patients receiving proton radiotherapy.
|
|
Academic Article
|
Association of Medicaid Insurance With Survival Among Patients With Small Cell Lung Cancer.
|
|
Academic Article
|
[Combination of Radiation Therapy and Immunotherapy for Non-small Cell Lung Cancer: Peer Exchange on Frontier Academic Topics].
|
|
Academic Article
|
Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC.
|
|
Academic Article
|
American Radium Society Appropriate Use Criteria on Radiation Therapy for Extensive-Stage SCLC.
|
|
Academic Article
|
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial.
|
|
Academic Article
|
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials.
|
|
Academic Article
|
American Radium Society Appropriate Use Criteria: Radiation Therapy for Limited-Stage SCLC 2020.
|
|
Academic Article
|
Could the clinical target volume be omitted for radiotherapy of locally advanced non-small cell lung cancer in the modern era?
|
|
Academic Article
|
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.
|
|
Academic Article
|
Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non-small-cell Lung Cancer.
|
|
Academic Article
|
Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study.
|
|
Academic Article
|
Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical Trial.
|
|
Academic Article
|
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.
|
|
Academic Article
|
American Radium Society Appropriate Use Criteria for Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer.
|
|
Academic Article
|
SABR for operable stage I non-small-cell lung cancer: comparison to surgery - Authors' reply.
|
|
Academic Article
|
Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer.
|
|
Academic Article
|
Local Consolidative Therapy Versus Systemic Therapy Alone for Metastatic Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
|
|
Academic Article
|
Optimize Local Therapy for Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer to Enhance Survival.
|
|
Academic Article
|
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
|
|
Academic Article
|
International consensus on radiotherapy in metastatic non-small cell lung cancer.
|
|
Academic Article
|
Treatment-related pulmonary adverse events induced by chemoradiation and Durvalumab affect survival in locally advanced non-small cell lung cancer.
|
|
Academic Article
|
Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival.
|
|
Academic Article
|
Neoadjuvant immunotherapy for advanced, resectable non-small cell lung cancer: A systematic review and meta-analysis.
|
|
Academic Article
|
NCCN Guidelines? Insights: Non-Small Cell Lung Cancer, Version 2.2023.
|
|
Academic Article
|
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.
|
|
Academic Article
|
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial.
|
|
Academic Article
|
Stereotactic body proton therapy for early stage non-small cell lung cancer - Technical challenges and solutions: The MD Anderson experience.
|
|
Academic Article
|
Metformin in Conjunction With Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer: Long-term Results of a Prospective Phase II Clinical Trial.
|
|
Academic Article
|
Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma.
|
|
Academic Article
|
American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non-Small Cell Lung Cancer.
|